The development of novel and selective p56(lck) tyrosine kinase inhibitors

James L. Bullington, Julie C. Cameron, Janet E. Davis, John H. Dodd, Crafford A. Harris, James R. Henry, J. Lee Pellegrino-Gensey, Kenneth C. Rupert, John J. Siekierka

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Early T-cell receptor mediated signal transduction involves the activation of several tyrosine protein kinases. One of these tyrosine kinases, p56(lck), is expressed primarily in T-cells and Natural Killer (NK) cells and has been shown to be critical for their proliferative and effector functions. Indandiones have been identified as a potent and selective chemical class that inhibits p56(lck).

Original languageEnglish (US)
Pages (from-to)2489-2494
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Issue number18
StatePublished - Sep 22 1998

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry


Dive into the research topics of 'The development of novel and selective p56(lck) tyrosine kinase inhibitors'. Together they form a unique fingerprint.

Cite this